Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06197945
Other study ID # REC/RCR&AHS/23/0152
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2023
Est. completion date February 10, 2024

Study information

Verified date December 2023
Source Riphah International University
Contact Ali Raza, Masters
Phone 03326099065
Email araza.frahs@riphah.edu.pk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hamstring tightness is a common problem caused by a sedentary lifestyle and can have negative effects on posture and musculoskeletal function. It can lead to postural misalignment, increasing loading on the lumbar spine, increased pressure on inter-vertebral disc and potentially resulting in low back problems. Bowen technique and Mulligan Bent leg raise is used to treat conditions including hamstring tightness. The goal of this clinical trial is to compare the effects of mulligan bent leg raise with and without Bowen therapy on hamstring tightness in asymptomatic adults.


Description:

A randomized control trial will be conducted at Riphah Rehabilitation Center and Physiogic Physiotherapy clinic on 50 asymptomatic adults who meet the inclusion criteria will be recruited using non probability purposive sampling and randomly allocated using Random Allocation Software 2.0. Informed consent will be obtained from all participants. They will be divided into two groups which will contain 25 participants in each group. Group A will receive three alternate sessions of Mulligan Bent Leg Raise with Bowen therapy and Group B will receive three alternate sessions of Mulligan Bent leg Raise. The Mulligan Bent Leg Raise technique will be performed with 3 repetition, 3-4 times with 20 sec hold and one minute rest between each repetition.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date February 10, 2024
Est. primary completion date January 10, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Male/Female - Age group between 18-40 years - Unilateral limitation of SLR less than 75 degrees - Asymptomatic, active knee extension less than 160 degrees Exclusion Criteria: - Fracture of Lower limb - Individuals with soft tissue injury - Chronic back pain - Prolapsed Intervertebral disc - Any surgery was done for back, pelvis hip or knee. - Spinal deformity

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mulligan bent leg raise
Mulligan bent leg raise
Mulligan bent leg raise with Bowen therapy
Mulligan bent leg raise with Bowen therapy

Locations

Country Name City State
Pakistan Physiogic Physiotherapy Clinic Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Active Knee Extension Test The Active Knee Extension Test is used to assess hamstring muscle length and the range of active knee extension in the position of hip flexion. A knee flexion angle of 20 ° or less is considered normal ROM on the AKE. The AKE has been found to have high reliability for intra-rater agreement (ICC = .86-.99) and moderate inter-rater reliability (ICC = .76-.89) 1 week
Primary Sit and Reach Test The Sit and reach test is one of the linear flexibility tests which helps to measure the extensibility of the hamstrings and lower back. Previous studies indicated that reliability estimate for Sit and reach test are consistently higher (.96 < R < .99) 1 week
Primary Straight Leg Raise Test also called the Lasegue test, Normal ROM for the PSLR has been reported as 80 ° of hip flexion. The PSLR has been reported to have high intra-rater (r = .91) and inter-rater (r = .93) reliability 1 week
See also
  Status Clinical Trial Phase
Completed NCT03361592 - The Immediate Effects of Spinal Manipulative Therapy on Kinetic and Kinematic Symmetry. N/A
Completed NCT04665193 - An Approach to Screening for COVID-19 at Vancouver Airport N/A
Not yet recruiting NCT02238028 - Intervention Study on the Health Effects of Wearing Particulate Filtering Respirators N/A
Completed NCT03455933 - Action Mechanisms of Shock Waves on Pain N/A
Completed NCT05377164 - Long Term Effects of Different Dietary Protocols on Determinants of Health in Patients' Lymphocytes
Completed NCT04480398 - Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
Completed NCT05210231 - Effects of Transcranial Direct Current Stimulation (tDCS) on Rotator Cuff Fatigue. N/A
Completed NCT05899244 - Influence of Muscle Stretching and Neural Mobilizations on Lower Limbs Range of Motion in Asymptomatic Subjects. N/A
Completed NCT04387032 - Impact of Manipulation of Sacroiliac Joints on the Static Balance of the Body N/A
Recruiting NCT03237039 - Classification of the Sagittal Profile of the Spine in Asymptomatic Elderly Subjects N/A
Completed NCT06048237 - Investigating Diaphragm Thickness and Mobility in Healthy Parous and Nulliparous Volunteers Using RUSI
Completed NCT04775628 - Forces and Translation Distance During an Inferior Glide of the Shoulder N/A
Not yet recruiting NCT06395675 - Clinical Evaluation of the ID NOW™ CT/NG Test N/A
Recruiting NCT06215040 - The Treatment Effect for Asymptomatic Common Bile Duct Stone
Completed NCT04741893 - Anal Canal Functional Assessment Using EndoFLIP N/A
Completed NCT04785079 - Instrument Assisted Soft Tissue Mobilization Effect on Blood Flow N/A
Completed NCT04360668 - Muscle Energy Techniques and Trigger Point Therapy in Asymptomatic Persons With Latent Trigger Point N/A
Completed NCT04367740 - ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19
Terminated NCT04346667 - Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds Phase 4
Not yet recruiting NCT05911828 - A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers Phase 1